Data di Pubblicazione:
2014
Citazione:
Mutation-targeted personalised medicine for cystic fibrosis / C. Colombo. - In: THE LANCET RESPIRATORY MEDICINE. - ISSN 2213-2600. - 2:11(2014 Nov), pp. 863-865. [10.1016/S2213-2600(14)70191-2]
Abstract:
Comment on Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST).
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
C. Colombo
Link alla scheda completa: